Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery
Pharmaceutics · 31.03.2023 · 15 (4) · 1117
DOI: 10.3390/pharmaceutics15041117 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 31.03.2023. Verfasst von Yoo Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, Basic Science Research Program through the National Research Foundation of Korea (NRF), National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Bladder cancer (BC) is a heterogeneous disease that a tumor develops in the bladder lining and in some cases, the bladder muscle. Chemotherapy and immunotherapy are commonly used to treat bladder cancer. However, chemotherapy can cause burning and irritation in the bladder while BCG immunotherapy, which is the main type of intravesical immunotherapy for bladder cancer, can also cause burning in the bladder and flu-like symptoms. Thus, drugs originating from natural products have attracted much attention due to the reports that they have anti-cancer properties with low adverse effects. In this study, eighty-seven papers that dealt with natural products preventing or treating bladder cancer were reviewed. The studies were classified into the following mechanism: 71 papers on cell death, 5 papers on anti-metastasis, 3 papers on anti-angiogenesis, 1 paper on anti-resistance, and 7 papers on clinical trials. Most of the natural products that induced apoptosis up-regulated proteins such as caspase-3 and caspase-9. Regarding anti-metastasis, MMP-2 and MMP-9 are regulated frequently. Regarding anti-angiogenesis, HIF-1α and VEGF-A are down-regulated frequently. Nevertheless, the number of papers regarding anti-resistance and clinical trial are too few, so more studies are needed. In conclusion, this database will be useful for future in vivo studies of the anti-bladder cancer effect of natural products, in the process of selecting materials used for the experiment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Chunhoo Cheon, Bonglee Kim
Förderung
- NIEHS NIH HHS
- Basic Science Research Program through the National Research Foundation of Korea (NRF)
- National Research Foundation of Korea (NRF)
- Ministry of Health & Welfare, Republic of Korea
- Ministry of Science and ICT
Zitieren
APA
Kang, Y., Park, C., Lee, H., Kang, S., Cheon, C., & Kim, B. (2023). Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery. Pharmaceutics, 15(4), 1117. https://doi.org/10.3390/pharmaceutics15041117
Vancouver
Kang Y, Park C, Lee H, Kang S, Cheon C, Kim B. Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery. Pharmaceutics. 2023;15(4):1117. doi:10.3390/pharmaceutics15041117
BibTeX
@article{Kang2023,
author = {Kang, Yoo and Park, Chelin and Lee, Heemin and Kang, Sojin and Cheon, Chunhoo and Kim, Bonglee},
title = {Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {4},
pages = {1117},
doi = {10.3390/pharmaceutics15041117}
}
EUVIMED